Table 4 Multivariable logistic regression analysis of possible predictors of early neurological deterioration
Crude OR (95% CI) | P-value | Adjusted OR (95% CI) | P-value | |
|---|---|---|---|---|
Model 1 (continuous) | ||||
Age | 1.02 [1.00-1.03] | 0.094 | 1.01 [0.99–1.03] | 0.202 |
Diabetes | 1.58 [1.01–2.46] | 0.046 | 1.12 [0.64–1.95] | 0.692 |
Initial NIHSS score | 1.06 [1.03–1.09] | < 0.001 | 1.04 [1.01–1.08] | 0.021 |
Thrombolytic therapy | 2.65 [1.54–4.56] | < 0.001 | 2.06 [1.14–3.73] | 0.017 |
Glycated albumin* | 3.86 [1.63–9.14] | 0.002 | 3.24 [1.10–9.50] | 0.033 |
WBC counts* | 1.97 [1.02–3.82] | 0.045 | 1.69 [0.85–3.37] | 0.135 |
Model 2 (Categorical) | ||||
Age | 1.02 [1.00-1.03] | 0.094 | 1.01 [0.99–1.03] | 0.256 |
Diabetes | 1.58 [1.01–2.46] | 0.046 | 1.15 [0.67–1.97] | 0.621 |
Initial NIHSS score | 1.06 [1.03–1.09] | < 0.001 | 1.04 [1.01–1.08] | 0.021 |
Thrombolytic therapy | 2.65 [1.54–4.56] | < 0.001 | 2.10 [1.16–3.80] | 0.015 |
GA > 16.0% | 2.09 [1.34–3.27] | 0.001 | 1.82 [1.05–3.15] | 0.034 |
WBC counts* | 1.97 [1.02–3.82] | 0.045 | 1.77 [0.89–3.53] | 0.103 |